Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Serum interleukin-6 concentration in patients with pemphigus

Thai Van Thanh Le, Anh Tuan Ngo, Quoc Hung Ta, The Bich Thanh Vuong

01-02-2024

https://doi.org/10.4081/dr.2024.9868

937

PDF: 485

HTML: 29
Autoinflammatory diseases: what is behind them and what is new?

Michele Maalouly, Serena Saade, Mazen Kurban

29-12-2022

https://doi.org/10.4081/dr.2023.9625

1906

PDF: 597

HTML: 166
Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum

Fitri Kadarsih Banjar, Farida Tabri, Sri Vitayani Muchtar, Mochammad Hatta, Khaeruddin Djawad, Farida Ilyas, Sitti Musafirah, Muhammad Nasrum Massi, Agussalim Bukhari, Andi Alfian Zainuddin

12-09-2023

https://doi.org/10.4081/dr.2023.9773

997

PDF: 494

HTML: 28
Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Chuyen Thi Hong Nguyen, Liem Viet Quoc Tran

27-11-2024

https://doi.org/10.4081/dr.2024.10090

901

PDF: 438

HTML: 33
Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata

Trang Thi Thuy Le, Thang Tat Nguyen, Chuyen Thi Hong Nguyen, Hao Trong Nguyen, Trung The Van

27-10-2021

https://doi.org/10.4081/dr.2021.9398

3189

PDF: 624

HTML: 17
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

1176

PDF: 579

HTML: 28
Neutrophilic urticarial dermatosis without systemic disease: case report

Sukaina Al Haddad, Abdulrahman Alfawzan, Maisa Alfalah , Manea Alharbi

30-01-2024

https://doi.org/10.4081/dr.2024.9756

1026

PDF: 762

HTML: 61
Atopic dermatitis: a brief review of recent advances in its management

Sultan Daghafak Alenazi

23-05-2023

https://doi.org/10.4081/dr.2023.9678

2534

PDF: 1456

HTML: 128
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

1377

PDF: 644

HTML: 29
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

12-11-2024

https://doi.org/10.4081/dr.2024.10080

1395

PDF: 761

HTML: 50
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2870

PDF: 1017

HTML: 40
Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo

Louise Rottboell, Sarah de Foenss, Kenneth Thomsen, Helle Christiansen, Stine M. Andersen, Thomas N. Dam, Cecilia Rosada, Karin Stenderup

17-12-2015

https://doi.org/10.4081/dr.2015.6246

3244

PDF: 981

HTML: 766
Implications of interleukin-17 in psoriatic lesions as Koebner phenomenon caused by recurrent occupational burns

Ayumi Sato, Takeshi Fukumoto, Ai Yoshioka, Chikako Nishigori

27-10-2022

https://doi.org/10.4081/dr.2022.9567

1042

PDF: 544

HTML: 22
Immunohistochemical expression of interleukin β in papule biopsies from patients with acne vulgaris

Le Thai Van Thanh, Le Vi Anh, Tran Huong Giang, Ta Quoc Hung, Van The Trung, Nguyen Lam Vuong

17-03-2022

https://doi.org/10.4081/dr.2022.9444

1247

PDF: 629

HTML: 31
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

21-11-2022

https://doi.org/10.4081/dr.2022.9447

1436

PDF: 434

HTML: 54
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

1126

PDF: 595

HTML: 98
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo

30-05-2025

https://doi.org/10.4081/dr.2025.10414

905

PDF: 477

HTML: 54
Telangiectasia Macularis Eruptiva Perstans: more than skin deep

Casey E. Watkins, Winston B. Bokor, Stuart Leicht, George Youngberg, Guha Krishnaswamy

e12

29-07-2011

https://doi.org/10.4081/dr.2011.e12

11820

PDF: 2264

HTML: 2307
Mendelian randomization analysis of the causal relationship between immune cells and keloid

Jingwen Zou, Pengkhun Nov, Kunpeng Du

23-10-2024

https://doi.org/10.4081/dr.2024.10106

894

PDF: 470

SUPPLEMENTARY MATERIAL: 164

HTML: 23
Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

11-11-2024

https://doi.org/10.4081/dr.2024.10140

1101

PDF: 583

SUPPLEMENTARY MATERIAL: 189

HTML: 24
Improvement of atopic dermatitis and alopecia universalis with dupilumab

Lama Alotaibi, Abdulrahman Alfawzan, Raghad Alharthi, Afaf Al sheikh

28-12-2021

https://doi.org/10.4081/dr.2022.9359

1424

PDF: 595

HTML: 55
Successful use of dupilumab in a patient with atopic dermatitis and autosomal dominant polycystic kidney disease: a case report

Arlind Kalaja, Barbara Cocuroccia, Donatella Sordi, Anna Dattolo, Sabatino Pallotta, Ignazio Stanganelli, Filomena Russo

04-06-2026

https://doi.org/10.4081/dr.2026.10522

401

PDF: 222
Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

11-10-2017

https://doi.org/10.4081/dr.2017.7079

1456

PDF: 694

HTML: 149
Effects of canary seed on two patients with disseminated granuloma annulare

Lily Park, Claudia Green, Sergey Arutyunyan, Gabriella Vasile, Christopher Buckley, Eduardo Weiss

23-12-2022

https://doi.org/10.4081/dr.2023.9614

1659

PDF: 575

HTML: 528
Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

Anna Paola Lugli, Niccolò Gori, Elena Ippoliti, Benedetta Ambrosio, Ketty Peris

03-02-2026

https://doi.org/10.4081/dr.2026.10644

795

PDF: 526

1 - 25 of 108 items 1 2 3 4 5 > >>

Search

Search Results

Serum interleukin-6 concentration in patients with pemphigus

Autoinflammatory diseases: what is behind them and what is new?

Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum

Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Neutrophilic urticarial dermatosis without systemic disease: case report

Atopic dermatitis: a brief review of recent advances in its management

Erythrodermic psoriasis improved by tildrakizumab

Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo

Implications of interleukin-17 in psoriatic lesions as Koebner phenomenon caused by recurrent occupational burns

Immunohistochemical expression of interleukin β in papule biopsies from patients with acne vulgaris

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Telangiectasia Macularis Eruptiva Perstans: more than skin deep

Mendelian randomization analysis of the causal relationship between immune cells and keloid

Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Improvement of atopic dermatitis and alopecia universalis with dupilumab

Successful use of dupilumab in a patient with atopic dermatitis and autosomal dominant polycystic kidney disease: a case report

Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Effects of canary seed on two patients with disseminated granuloma annulare

Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

authors

reviewers

Categories

indexing

dermatopathology